Generative AI and digital twins: shaping a paradigm shift from precision to truly personalized medicine.

Journal: Expert opinion on drug discovery
Published Date:

Abstract

No abstract available for this article.

Authors

  • Maria Bordukova
    Data & Analytics, Pharmaceutical Research and Early Development, Roche Innovation Center Munich (RICM), Penzberg, Germany.
  • Alina J Arneth
    Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia.
  • Nikita Makarov
    Data & Analytics, Pharmaceutical Research and Early Development, Roche Innovation Center Munich (RICM), Penzberg, Germany.
  • Robyn M Brown
    Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia.
  • Elena K Schneider-Futschik
    Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia.
  • Shyamali C Dharmage
    Allergy and Lung Health Unit, School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.
  • Elif Ekinci
    Department of Medicine, Melbourne Medical School, The University of Melbourne, Australia and Department of Endocrinology, Austin Health, Melbourne, Australia.
  • Peter J Crack
    Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia.
  • Danny M Hatters
    Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia.
  • Alastair G Stewart
    Structural Biology Laboratory, Victor Chang Cardiac Research Institute, Sydney 2010 New South Wales, Australia.
  • David Stroud
  • Teresa Sadras
    Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.
  • Gary P Anderson
    Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia.
  • Fabian Schmich
    From the Data Science, Pharmaceutical Research and Early Development Informatics (pREDi), Roche Innovation Center Munich (RICM), Penzberg, Germany.
  • Raul Rodriguez-Esteban
    Roche Pharmaceutical Research and Early Development, pRED Informatics, Roche Innovation Center, Basel, Switzerland.
  • Michael P Menden
    Institute of Computational Biology, Helmholtz Zentrum München-German Research Center for Environmental Health, 85764 Neuherberg, Germany.

Keywords

No keywords available for this article.